The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Tissue engineering for wound care management is the use of mechanical and chemical processing of materials to manufacture products that may substitute or replace all or some components that make up a normal skin (e.g. , epidermis and/or dermis, cells, and matrix). GlobalData uses proprietary data and analytics to provide a comprehensive report on the tissue engineered – skin substitutes devices market, including market shares of different players within Austria. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the tissue engineered – skin substitutes market in Austria was Allergan followed by Integra LifeSciences, Smith & Nephew and LifeNet Health.
Tissue Engineered Skin Substitutes can be derived from human tissue (autologous or allogenic), non-human tissue (enographic), a composite, or synthetic materials. Acellular or cellular may consist of a synthetic epidermis and a collagen-based dermis to encourage formation of new tissue. In products that have a synthetic epidermis, this may be a temporary wound covering. This category consists of cellular skin substitutes and acellular skin substitutes.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the tissue engineered – skin substitutes devices market within Austria was expected to be over $4m in 2022.
For the latest complete market share analysis of tissue engineered – skin substitutes device market in Austria, buy the report here.